Pamela B. Davis

10.9k total citations · 3 hit papers
152 papers, 7.8k citations indexed

About

Pamela B. Davis is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Pamela B. Davis has authored 152 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pulmonary and Respiratory Medicine, 38 papers in Molecular Biology and 23 papers in Physiology. Recurrent topics in Pamela B. Davis's work include Cystic Fibrosis Research Advances (88 papers), Neonatal Respiratory Health Research (53 papers) and Tracheal and airway disorders (22 papers). Pamela B. Davis is often cited by papers focused on Cystic Fibrosis Research Advances (88 papers), Neonatal Respiratory Health Research (53 papers) and Tracheal and airway disorders (22 papers). Pamela B. Davis collaborates with scholars based in United States, Russia and Czechia. Pamela B. Davis's co-authors include Michael W. Konstan, Paul A. di Sant'Agnese, Mitchell L. Drumm, Pamela J. Byard, Charles L. Hoppel, Rong Xu, Mark Schluchter, Dianne Kube, James F. Chmiel and Assem Ziady and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Pamela B. Davis

149 papers receiving 7.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cystic Fibrosis

1996 641 citations Pamela B. Davis, Mitchell L. Drumm et al. American Journal of Respiratory and Critical Care Medicine profile →
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis

1995 550 citations Michael W. Konstan, Pamela B. Davis et al. profile →
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

2021 166 citations QuanQiu Wang, Pamela B. Davis et al. Alzheimer s & Dementia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela B. Davis United States	47	4.9k	2.0k	884	781	556	152	7.8k
K. De Boeck Belgium	49	7.0k 1.4×	1.4k 0.7×	1.2k 1.4×	1.0k 1.3×	576 1.0×	250	8.9k
James R. Yankaskas United States	53	6.7k 1.4×	3.5k 1.7×	965 1.1×	1.1k 1.4×	982 1.8×	103	10.8k
Moira L. Aitken United States	46	4.2k 0.9×	1.3k 0.6×	1.0k 1.1×	851 1.1×	852 1.5×	138	6.3k
Eitan Kerem Israel	50	7.1k 1.5×	1.8k 0.9×	1.1k 1.2×	1.4k 1.8×	729 1.3×	263	10.0k
David W. Reid Australia	45	2.5k 0.5×	2.5k 1.2×	1.4k 1.6×	937 1.2×	426 0.8×	219	7.1k
Karen McCoy United States	38	4.7k 1.0×	1.2k 0.6×	650 0.7×	890 1.1×	349 0.6×	153	6.3k
John P. Clancy United States	44	3.4k 0.7×	1.7k 0.8×	574 0.6×	475 0.6×	540 1.0×	142	5.8k
Elizabeth Tullis Canada	45	6.4k 1.3×	1.1k 0.6×	649 0.7×	777 1.0×	321 0.6×	158	8.0k
Carlos Milla United States	49	4.3k 0.9×	1.0k 0.5×	600 0.7×	632 0.8×	801 1.4×	172	7.3k
Isao Ito Japan	41	2.4k 0.5×	1.4k 0.7×	1.6k 1.8×	805 1.0×	725 1.3×	265	6.7k

Countries citing papers authored by Pamela B. Davis

Since Specialization

Citations

This map shows the geographic impact of Pamela B. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela B. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela B. Davis more than expected).

Fields of papers citing papers by Pamela B. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela B. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela B. Davis. The network helps show where Pamela B. Davis may publish in the future.

Co-authorship network of co-authors of Pamela B. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela B. Davis. A scholar is included among the top collaborators of Pamela B. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela B. Davis. Pamela B. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, William Yang, Pamela B. Davis, Xin Qi, et al.. (2025). Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study. Journal of Alzheimer s Disease. 106(4). 1509–1522. 4 indexed citations

Wang, Lindsey, Nathan A. Berger, Pamela B. Davis, et al.. (2023). Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0–5 years, January 2010–January 2023. Family Medicine and Community Health. 11(4). e002453–e002453. 19 indexed citations

Zheng, Chunlei, Nathanael R. Fillmore, Jaime Ramos‐Cejudo, et al.. (2021). Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer s & Dementia. 18(6). 1248–1259. 20 indexed citations

Wang, QuanQiu, Pamela B. Davis, Xin Qi, et al.. (2021). Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization. Alzheimer s Research & Therapy. 13(1). 177–177. 26 indexed citations

Davis, Pamela B.. (2011). The trappings of poverty: the role of assets and liabilities in socio-economic mobility in rural Bangladesh. CPRC Working Paper 195.. 84(6). 1–39. 1 indexed citations

Nichols, David P., Assem Ziady, Samuel Shank, Jean Eastman, & Pamela B. Davis. (2009). The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(5). L828–L836. 40 indexed citations

Konstan, Michael W., Mark Schluchter, Wei Xue, & Pamela B. Davis. (2007). Clinical Use of Ibuprofen is Associated with Slower FEV1 Decline in Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 176(11). 1084–1089. 136 indexed citations

Davis, Pamela B. & Mitchell L. Drumm. (2004). Some like it hot: curcumin and CFTR. Trends in Molecular Medicine. 10(10). 473–475. 9 indexed citations

Ferkol, Thomas W., Leah A. Cohn, Thomas E. Phillips, Arnold L. Smith, & Pamela B. Davis. (2003). Targeted Delivery of Antiprotease to the Epithelial Surface of Human Tracheal Xenografts. American Journal of Respiratory and Critical Care Medicine. 167(10). 1374–1379. 16 indexed citations

10.

Ferkol, Thomas W., et al.. (2000). Transport of Bifunctional Proteins Across Respiratory Epithelial Cells via the Polymeric Immunoglobulin Receptor. American Journal of Respiratory and Critical Care Medicine. 161(3). 944–951. 17 indexed citations

11.

Tscheikuna, Jamsak, et al.. (2000). Effect of Pseudomonas Infection on Weight Loss, Lung Mechanics, and Cytokines in Mice. American Journal of Respiratory and Critical Care Medicine. 161(1). 271–279. 99 indexed citations

12.

Davis, Pamela B., Mitchell L. Drumm, & Michael W. Konstan. (1996). Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 154(5). 1229–1256. 641 indexed citations breakdown →

13.

Sharma, Girish, Michael F. Tosi, R C Stern, & Pamela B. Davis. (1995). Progression of Pulmonary Disease After Disappearance of Pseudomonas in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 152(1). 169–173. 13 indexed citations

14.

Infeld, Michael, Jennifer Brennan, & Pamela B. Davis. (1993). Human Fetal Lung Fibroblasts Promote Invasion of Extracellular Matrix by Normal Human Tracheobronchial Epithelial Cells In Vitro : A Model of Early Airway Gland Development. American Journal of Respiratory Cell and Molecular Biology. 8(1). 69–76. 17 indexed citations

15.

Chung, Youngran, Carolyn M. Kercsmar, & Pamela B. Davis. (1991). Ferret Tracheal Epithelial Cells Grown In Vitro are Resistant to Lethal Injury by Activated Neutrophils. American Journal of Respiratory Cell and Molecular Biology. 5(2). 125–132. 8 indexed citations

16.

Hornof, W. J., et al.. (1987). Pharmacokinetics of aerosolized iodine 123 labeled alpha 1 antiprotease in the conscious spontaneously ventilating sheep. American Review of Respiratory Disease. 2. 356. 1 indexed citations

17.

Davis, Pamela B.. (1986). Lymphocyte and Granulocyte Phosphatidylethanolamine N-Methyltransferase: Properties and Activity in Cystic Fibrosis. Pediatric Research. 20(12). 1290–1296. 4 indexed citations

18.

Davis, Pamela B., Van S. Hubbard, Karen McCoy, & Lynn M. Taussig. (1983). Familial bronchiectasis. The Journal of Pediatrics. 102(2). 177–185. 10 indexed citations

19.

Davis, Pamela B. & Philip Lieberman. (1982). Normal alpha2-adrenergic responses in platelets from patients with asthma. Journal of Allergy and Clinical Immunology. 69(1). 35–38. 6 indexed citations

20.

Davis, Pamela B. & Paul A. di Sant'Agnese. (1980). A Review. Cystic Fibrosis at Forty—Quo Vadis?. Pediatric Research. 14(2). 83–87. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact